FedEx (NYSE:FDX) reported quarterly earnings of $3.44 per share which beat the analyst consensus estimate of $3.35 by 2.69 percent. This is a 21.28 percent decrease over earnings of $4.37 per share from the same period last year.
Guardant Health Announces Collaboration With AstraZeneca To Develop Companion Diagnostic To Identify Patients With ESR1-mutated Metastatic Breast Cancer
Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, announced today it has entered into a collaboration with AstraZeneca to pursue the development, regulatory approval and commercialization of the
